Improving disease surveillance, strengthening primary healthcare, and being able to expand quickly during a crisis are some of the important lessons from the COVID-19 pandemic that can be applied to ‘Disease X’, according to health experts speaking on a panel at the World Economic Forum on Wednesday. “Disease X is a placeholder for unknown diseases,” […] Continue reading ->
“It’s not just about people with disabilities, this is about all of us,” stresses Pascal Bijleveld, the CEO of ATscale Global Partnership, an organization established in 2018 to advocate for assistive technologies (AT) access, especially in low- and middle-income countries. The first-ever global campaign to expand access, ‘Unlock the Everyday’, was launched on Tuesday at […] Continue reading ->
The first clinical trial of a vaccine for Nipah, a deadly communicable disease mostly found in South-East Asia, is about to start, the Oxford Vaccine Group announced. Despite 25 years of outbreaks and its WHO status of a priority disease, there is no treatment or vaccine for Nipah up to this date.  “This vaccine trial […] Continue reading ->
Cabo Verde was certified as malaria-free on Friday by the World Health Organization (WHO), only the third African country to have achieved this milestone. The country, an archipelago of 10 islands off the West African coast near Senegal, joins 43 countries including African countries Mauritius and Algeria in eliminating malaria.  Its last indigenous malaria case […] Continue reading ->
The rising number of US citizens declining vaccinations is threatening population immunity to certain diseases, according to two US Food and Drug Administration (FDA) leaders. “The situation has now deteriorated to the point that population immunity against some vaccine-preventable infectious diseases is at risk, and thousands of excess deaths are likely to occur this season […] Continue reading ->
The World Health Organization (WHO) has added the R21/Matrix-M malaria vaccine to its list of ‘prequalified’ vaccines, paving the way for bulk procurement and mass deployment of the new vaccine across malaria-endemic countries by UNICEF and other global health agencies. The prequalification of the world’s second malaria vaccine, developed by Oxford University and manufactured by […] Continue reading ->
The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading ->